STERIS
STE | NYSE
$207.69
+$0.72 (+0.35%)
Sep 22, 2026, 12:41 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 30, 2026 | FY 2025 Mar 30, 2025 | FY 2024 Mar 30, 2024 | FY 2023 Mar 30, 2023 | FY 2022 Mar 30, 2022 | FY 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 5.94B | 5.46B | 5.14B | 4.54B | 4.22B | 3.11B |
Cost of Revenue | 3.31B | 3.06B | 2.92B | 2.56B | 2.34B | 1.76B |
Gross Profit | 2.63B | 2.4B | 2.22B | 1.98B | 1.88B | 1.34B |
Operating Income | 1.1B | 866.64M | 836.12M | 791.1M | 477.82M | 548.37M |
Interest Income | 9.8M | 8.4M | 11.04M | n/a | 6.28M | 6.35M |
Pretax Income | 1.05B | 796.21M | 702.81M | 680.27M | 366.8M | 517.53M |
Net Income | 785.1M | 614.64M | 378.24M | 107.03M | 243.89M | 397.4M |
Selling & General & Admin | 1.41B | 1.33B | 1.25B | 1.09B | 1.32B | 731.32M |
Research & Development | 112.9M | 107.65M | 103.68M | 98.48M | 86.66M | 66.33M |
Other Expenses | 4.1M | 94.2M | 26.05M | 485K | 48K | -2.91M |
Operating Expenses | 1.52B | 1.54B | 1.38B | 1.19B | 1.41B | 794.73M |
Interest Expense | 60.7M | 86.26M | 144.35M | 110.84M | 89.49M | 37.18M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.83B | 4.59B | 4.3B | 3.75B | 3.75B | 2.56B |
Income Tax Expense | 262.2M | 184.65M | 149.53M | 124.07M | 82.34M | 120.66M |
Shares Outstanding (Basic) | 98.2M | 98.58M | 98.79M | 99.71M | 97.54M | 85.2M |
Shares Outstanding (Diluted) | 98.7M | 99.07M | 99.36M | 100.25M | 98.33M | 85.9M |
EPS (Basic) | 7.93 | 6.24 | 3.83 | 1.07 | 2.50 | 4.66 |
EPS (Diluted) | 7.93 | 6.20 | 3.81 | 1.07 | 2.48 | 4.63 |
EBITDA | 1.59B | 1.36B | 1.41B | 1.23B | 1.01B | 773.95M |
EBIT | 1.11B | 882.47M | 847.16M | 811.97M | 456.29M | 554.71M |
Depreciation & Amortization | 486.5M | 476.22M | 565.24M | 422.53M | 553.1M | 219.24M |
Add to Watchlist
Select watchlists to add or remove STE